| Mrs Kim Alane Lui, APN | |
|
1061 Avenue C, Bayonne, NJ 07002-3328 | |
| (201) 243-0800 | |
| Not Available |
| Full Name | Mrs Kim Alane Lui |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 1061 Avenue C, Bayonne, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366222788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NO10611300 (New Jersey) | Secondary |
| 363LP2300X | Nurse Practitioner - Primary Care | 26NJ14876400 (New Jersey) | Primary |
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Researchers from Mount Sinai School of Medicine have found that patients admitted to hospice care who have an implantable cardioverter defibrillator (ICD) are rarely having their ICDs deactivated and are receiving electrical shocks from these devices near the end of life. This first-of-its-kind study of hospice patients with ICDs is published in the March 2, 2010 issue of the Annals of Internal Medicine.
Dr. Keith Corl was working in a Las Vegas emergency room when a patient arrived with chest pain. The patient, wearing his street clothes, had a two-minute exam in the triage area with a doctor, who ordered an X-ray and several other tests.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has achieved enrolled of over 400 subjects in its pivotal global Phase III study of its flagship product, Generex Oral-lyn™, a proprietary buccal insulin spray product designed to replace prandial injections of insulin.
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results also suggest that certain patients with intermediate-risk disease can receive less aggressive adjuvant treatment, or perhaps forego it altogether. Avoiding chemotherapy spares patients from treatment side effects and long-term health risks, such as cardiovascular disease and development of a second cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kim Alane Lui, APN 1061 Avenue C Ste 205, Bayonne, NJ 07002-3328 Ph: (201) 843-0800 | Mrs Kim Alane Lui, APN 1061 Avenue C, Bayonne, NJ 07002-3328 Ph: (201) 243-0800 |
News Archive
Researchers from Mount Sinai School of Medicine have found that patients admitted to hospice care who have an implantable cardioverter defibrillator (ICD) are rarely having their ICDs deactivated and are receiving electrical shocks from these devices near the end of life. This first-of-its-kind study of hospice patients with ICDs is published in the March 2, 2010 issue of the Annals of Internal Medicine.
Dr. Keith Corl was working in a Las Vegas emergency room when a patient arrived with chest pain. The patient, wearing his street clothes, had a two-minute exam in the triage area with a doctor, who ordered an X-ray and several other tests.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has achieved enrolled of over 400 subjects in its pivotal global Phase III study of its flagship product, Generex Oral-lyn™, a proprietary buccal insulin spray product designed to replace prandial injections of insulin.
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results also suggest that certain patients with intermediate-risk disease can receive less aggressive adjuvant treatment, or perhaps forego it altogether. Avoiding chemotherapy spares patients from treatment side effects and long-term health risks, such as cardiovascular disease and development of a second cancer.
› Verified 6 days ago
Joy-marie Ann Therese Salle, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 988 Broadway, Bayonne, NJ 07002 Phone: 201-339-6111 | |
Mrs. Colleen Mernar, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 339 Avenue C, Bayonne, NJ 07002 Phone: 201-572-4601 | |
Samir M. Ousserghine, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 554 Avenue C Apt 1d, Bayonne, NJ 07002 Phone: 201-993-1616 | |
Josephine Apokumah Smith, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 29 E 29th St, Bayonne, NJ 07002 Phone: 201-858-5065 | |
Sherly Thenor, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 19 E 27th St, Bayonne, NJ 07002 Phone: 201-436-0033 | |
Marina Mikhail, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 668 Broadway, Bayonne, NJ 07002 Phone: 732-456-7777 | |
Marykate Laino, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1061 Avenue C, Bayonne, NJ 07002 Phone: 201-858-0800 |